AMVUTTRA

Serial Number 97057473
Registration 6897159
700

Registration Progress

Application Filed
Oct 3, 2021
Under Examination
Mar 22, 2022
Approved for Publication
Jan 25, 2022
Published for Opposition
Jan 25, 2022
Registered
Nov 8, 2022

Trademark Image

AMVUTTRA

Basic Information

Serial Number
97057473
Registration Number
6897159
Filing Date
October 3, 2021
Registration Date
November 8, 2022
Published for Opposition
January 25, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 8, 2022
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
1191 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-08)
Due Date
November 08, 2028
Grace Period Ends
May 08, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

21 events
Date Code Type Description Documents
Nov 8, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 1, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 30, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 1, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 1, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 15, 2022 IUAF S USE AMENDMENT FILED Loading...
Jul 15, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 15, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Mar 22, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 25, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 18, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 29, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 6, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of amyloidosis
First Use Anywhere: Jul 1, 2022
First Use in Commerce: Jul 5, 2022

Additional Information

Design Mark
The mark consists of the word AMVUTTRA and the design of a stylized double helix.

Classification

International Classes
005